AbbVie’s recent confirmation that it’s in talks to acquire Gilgamesh Pharmaceuticals for roughly $1 billion underscores its unrelenting push to replenish growth after Humira’s patent cliff.

US stocks traded higher on Wednesday, with the benchmark S&P 500 rising by 0.7%, the Nasdaq climbing by 0.9%, and the Dow Jones Industrial Average with a modest 0.3% increase.

According to a report by StreetInsider, an unnamed strategic buyer has offered $18 per share for the company, prompting Axogen to engage Centerview Partners to evaluate the proposal and potentially explore interest from other bidders.

Opendoor Technologies (OPEN) surged a massive 245% in July, capturing the attention of investors and analysts alike.

U.S. stocks dipped on Tuesday as Wall Street digested the latest release of corporate earnings, global trade tensions, and mixed economic data.

Comerica Inc. has recently found itself at the center of M&A speculation following a public push from HoldCo Asset Management to initiate a sales process.

Palo Alto Networks is reportedly in advanced talks to acquire CyberArk Software in a deal that could exceed $20 billion, marking one of the biggest technology takeovers of 2025